Find support and hope together

Lisa Curcio, MD, is a board-certified general surgeon and fellowship-trained surgical oncologist. She is currently the medical director of breast surgery at Northern Dutchess Hospital in Rhinebeck, New York. Dr. Curcio attended medical school at George Washington University in Washington, DC, where she also completed a residency in general surgery. She was invited to train in cancer surgery at City of Hope National Medical Center in Duarte, California. She was a recipient of the competitive U.S. Air Force Health Professions Scholarship Program. During his military service, Dr. Curcio served in the Army as chief surgical oncologist at Keesler Medical Center in Biloxi, Mississippi.

From 2003 to 2004, she served as program director for Susan G. Komen in Orange County and remains involved in Komen’s outreach efforts. She was on the board of directors of Kids Konnected, a nonprofit organization that helps children of cancer patients deal with the emotional toll of a cancer diagnosis. Currently, she serves on the board of directors of the Miles of Hope Breast Cancer Foundation, an organization dedicated to providing support services to those affected by breast cancer in New York’s Hudson Valley. Dr. Curcio also has a strong background in breast cancer research, having contributed to dozens of peer-reviewed articles. She is currently a member of Alpha’s Investigation Review Committee.

Her practice includes benign and malignant breast diagnostics. Dr. Curcio was diagnosed with breast cancer at the age of 37. Although her training was in surgical oncology, this experience motivated her to provide a high level of compassionate breast care and focus on breast surgery.

Dr. Curcio is passionate about treating the patient and individualizing the plan of care based on their specific needs. Dr. Curcio strongly believes that cancer care should include lifestyle changes to focus on healthier habits to reduce future events. Her practice also focuses on breast cancer risk reduction, education and access to genetic testing for patients with a family history of breast cancer.